(Q44314823)

1 December 2017

title

Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients (English)

1 reference

1 December 2017

11

1 reference

1 December 2017

2

Truls Østbye

1 reference

1 December 2017

10

Robert M Califf

1 reference

1 December 2017

Nancy M Allen LaPointe

5

object named as

Nancy M Allen LaPointe

1 reference

1 December 2017

6

Sana M Al-Khatib

1 reference

1 December 2017

1

Lesley H Curtis

1 reference

1 December 2017

Veronica Sendersky

3

1 reference

1 December 2017

Steve Hutchison

4

1 reference

1 December 2017

Sally Usdin Yasuda

7

1 reference

1 December 2017

Peter E Dans

8

1 reference

1 December 2017

Alan Wright

9

1 reference

1 December 2017

Kevin A Schulman

12

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

American Journal of Medicine

1 December 2017

published in

1 reference

1 December 2017

volume

114

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

135-141

1 reference

Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Drug-induced torsade de pointes. Incidence, management and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

A practical approach to torsade de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Torsades de pointes and proarrhythmia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Dofetilide, a new class III antiarrhythmic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

The QT interval and torsade de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Cardiotoxic effect with convulsions in terfenadine overdose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Inhibition and induction of cytochrome P450 and the clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Fluoxetine (Prozac) as a cause of QT prolongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Timing of new black box warnings and withdrawals for prescription medications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Representation of elderly persons and women in published randomized trials of acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Prescription-event monitoring--recent progress and future horizons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Comparison of different methods to estimate prevalence of drug use by using pharmacy records

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Data validity issues in using claims data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Drug interactions with cisapride: clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Dramatic inhibition of amiodarone metabolism induced by grapefruit juice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901455-9

10.1016/S0002-9343(02)01455-9

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference